AAAbdul Rehman Azam

Abdul Rehman Azam

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abdul Rehman Azam has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Therapeutic equivalence of intermittent and continuous phototherapy for neonatal jaundice: a systematic review & meta-analysis with regression and trial sequential analysis

    by Fahad Amin, Rija Fatima, Saira Iqbal, Abdul Rehman Azam, Tehreem Talab, Taimoor Hassan, Esha Naeem, Muhammad Talha, Mashal Zahid, Hurain Naeem

    Phototherapy is the mainstay treatment for neonatal hyperbilirubinemia, but the optimal delivery strategy remains debated. Intermittent phototherapy (IMPT) has been proposed as an alternative to continuous phototherapy (CPT) that may achieve comparable bilirubin reduction with fewer adverse effects. This systematic review and meta-analysis evaluated the comparative efficacy and safety of IMPT versus CPT in neonates with hyperbilirubinemia. PubMed, Embase, Scopus, Cochrane Library, and ClinicalTrials.gov were searched through June 2026 for randomized controlled trials comparing IMPT and CPT. Outcomes included rate of fall in bilirubin, follow-up bilirubin, phototherapy duration, hospital stay, and mortality. Random-effects meta-analysis pooled mean differences (MD) and risk ratios (RR) with 95% confidence intervals (CI). Subgroup, meta-regression, and Trial Sequential Analysis (TSA) were performed, and certainty of evidence was graded using GRADE. Twenty-six RCTs (3,891 neonates) were included. No significant difference was found between IMPT and CPT for rate of bilirubin fall, follow-up bilirubin, hospital stay, or mortality. IMPT significantly reduced phototherapy duration (MD - 10.40 h, 95% CI - 18.91 to - 1.88). Heterogeneity was substantial across outcomes. TSA indicated conclusive evidence of equivalence for bilirubin-related and hospital stay outcomes, while evidence for the duration reduction had not yet reached the required information size. Certainty of evidence ranged from low to very low. IMPT achieves outcomes comparable to CPT while significantly reducing treatment duration, supporting its use as a time-efficient alternative, though findings warrant cautious interpretation given low certainty of evidence. • IMPT and CPT show comparable bilirubin reduction, but prior comparisons relied on limited trials without assessing whether the evidence base is conclusive. • This review incorporates the latest trials, applies Cochrane-guided meta-regression, subgroup, leave-one-out, and Hartung-Knapp sensitivity analyses, and uses TSA to confirm conclusive equivalence across major outcomes.


  • Robot-Assisted Versus Standard Laparoscopic Radical Nephrectomy for Renal Tumors: An Updated Systematic Review And Meta-Analysis with Meta-Regression

    by Fahad Amin, Ammad Abid, Tahzeeb Afzal, Abdul Sami Ur Rehman Ghani, Taimoor Hassan, Abdul Rehman Azam, Salma Mohamed Awadallah, Maiza Naseer, Khadija Mohib, Arbab Khalid

  • Is There Any Role of Zinc and Copper in Severity and Progression of Osteoarthritis? A Review

    by Umaima Cheema, Meeram Noor, Hurain Naeem, Mahnoor Arfan, Abdul-Rehman Azam, Shamikha Cheema, Hafiz Muhammad Haris, Muhammad Raza

    Osteoarthritis (OA) is one of the most prevalent chronic diseases of the aging population, with an incidence of more than 250 million affected people and annual treatment costs exceeding $80 billion. Osteoarthritis involves pain, stiffness, reduced mobility, and swelling of the joints due to cartilage wear and tear and inflammation, which results in a broad system affecting the joints. This review focuses on the relationship between zinc and copper and the effects of these minerals on osteoarthritis. Osteoarthritis is a degenerative disease that currently affects millions of people and is characterized by the degradation of joint cartilage and inflammation. Zinc is crucial to the development of healthy cells, including cartilage, and copper keeps cartilage in balance and improves the immune response. If these elements are imbalanced, then symptoms of osteoarthritis may worsen, and studies have revealed that people with osteoarthritis exhibit increased levels of copper, which is the active factor in inflammation and cartilage breakdown. In osteoarthritis patients, the level of zinc is decreased, yet it plays an important role in bone and cartilage formation. Zinc and copper are interrelated because zinc has antioxidant properties, while copper might have a detrimental effect on cell injury. More investigations must be conducted on the therapeutic aspects of these processes and on how to improve the treatment of osteoarthritis. Knowledge of these relationships could allow for enhanced diagnosis, proper treatment, and therapy for people with osteoarthritis, hence enhancing quality of life.